BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18278402)

  • 1. [Advances in diagnosis and treatment of neurofibromatosis type 1].
    Zheng JW; Sun J; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2007 Dec; 16(6):561-9. PubMed ID: 18278402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
    Ferner RE; Huson SM; Thomas N; Moss C; Willshaw H; Evans DG; Upadhyaya M; Towers R; Gleeson M; Steiger C; Kirby A
    J Med Genet; 2007 Feb; 44(2):81-8. PubMed ID: 17105749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 (NF1): diagnosis and management.
    Ferner RE; Gutmann DH
    Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis 1: from lab bench to clinic.
    Ward BA; Gutmann DH
    Pediatr Neurol; 2005 Apr; 32(4):221-8. PubMed ID: 15797177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Care recommendations for type 1 neurofibromatosis].
    Donadio A; Garavelli L; Lorenzetti ME; Villani AR; Banchini G; Virdis R
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):83-7. PubMed ID: 11424620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral gingival enlargement in patient with neurofibromatosis type I.
    Asgary S; Aminzadeh N
    N Y State Dent J; 2012 Nov; 78(6):50-3. PubMed ID: 23488326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 clinical features and management.
    Scalzone M; Coccia P; Ruggiero A; Riccardi R
    Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)].
    Gómez M; Batista O
    Rev Med Chil; 2015 Oct; 143(10):1320-30. PubMed ID: 26633276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care.
    Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
    Clin Genet; 2016 Mar; 89(3):385-91. PubMed ID: 26081173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic manifestations in neurofibromatosis type 1.
    Kinori M; Hodgson N; Zeid JL
    Surv Ophthalmol; 2018; 63(4):518-533. PubMed ID: 29080631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
    Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T; Pfister SM; Rood B; Rodriguez FJ; Tabori U; Ramaswamy V; Zhu Y; Fangusaro J; Johnston SA; Gutmann DH
    Neuro Oncol; 2020 Jun; 22(6):773-784. PubMed ID: 32055852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
    Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of type 1 neurofibromatosis].
    Garavelli L; Donadio A; Sigorini M; Grassi L; Banchini G
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):89-95. PubMed ID: 11424621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Supervision for Children With Neurofibromatosis Type 1.
    Miller DT; Freedenberg D; Schorry E; Ullrich NJ; Viskochil D; Korf BR; ;
    Pediatrics; 2019 May; 143(5):. PubMed ID: 31010905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 1--an update and review for the primary pediatrician.
    Goldberg Y; Dibbern K; Klein J; Riccardi VM; Graham JM
    Clin Pediatr (Phila); 1996 Nov; 35(11):545-61. PubMed ID: 8953130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
    Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.